FCMI
Foresite Capital Management I Portfolio holdings
AUM
$21.4M
This Quarter Return
+8.54%
1 Year Return
-80.48%
3 Year Return
-40.72%
5 Year Return
–
10 Year Return
–
AUM
$166M
AUM Growth
+$166M
(-16%)
Cap. Flow
-$49M
Cap. Flow
% of AUM
-29.51%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
–
Top Buys
No buys this quarter
Top Sells
| 1 |
10x Genomics
TXG
|
$49M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
10x Genomics
TXG
$1.74B
| $147M | 88.53% | 750,000 -250,000 | -25% | -$49M |
|
2
Novavax
NVAX
$1.21B
| $14.2M | 8.55% | 66,810 | – | – |
|
|
EPZM
3
DELISTED
Epizyme, Inc
EPZM
| $2.44M | 1.47% | 293,759 | – | – |
|
|
XLRN
4
DELISTED
Acceleron Pharma Inc.
XLRN
| $2.4M | 1.45% | 19,100 | – | – |
|